Lumida
/CLBT
⌘K
Cellebrite DI Ltd

Cellebrite DI Ltd

CLBT
$15.44USD-2.46%-0.39 today

MARKET CAP

3.9B

P/E (TTM)

29.7x

FWD P/E

25.5x

DAY RANGE

$15 – $16

52W RANGE

$11
$20

The case for & against

Bull & Bear analysis

Bullish

Celebrite DI Ltd. (NASDAQ: CLBT) is a leading provider of digital intelligence and forensic solutions, primarily serving law enforcement, government agencies, and enterprises globally. With a focus on enhancing capabilities in public safety, the company leverages its expertise in mobile forensics, AI-driven digital evidence management, and an expanding range of solutions including SaaS tools. Celebrite is uniquely positioned to capitalize on increasing demands for advanced investigative technologies amid a backdrop of rising crime rates and geopolitical instability, which bolsters its growth trajectory in the digital forensics market.

Bull says

  • ARR grew 21% YoY to $493M in Q1 2026.
  • Revenue $128.3M and FCF $159M both up 19% YoY.
  • Gross margin 86% and adjusted EBITDA +29% YoY support profitability.
  • >90% subscription revenue boosts visibility and margin expansion.
  • Genesis AI launch targets a $12.5B investigative AI market.
  • DA Davidson Buy rating and $20 price target signal analyst confidence.

Bear says

  • Federal budget uncertainty could delay contracts and hinder ARR growth.
  • Negative earnings yield and dividend yield highlight near-term profitability pressures.
  • Genesis AI execution lags management estimates, risking adoption pace.
  • Intensifying digital-forensics competition may erode market share and margins.
  • Management expects normalized growth only by 2026, dampening near-term outlook.
  • Elevated leverage and high volatility heighten financial and stock-price risks.

Investment themes with CLBT

Software +1.28%

Cloud-based digital tools powering business productivity and innovation

PLTR · IBM · CRM
Quality Bubble +0.65%

High valuation companies with quality characteristics

TSLA · COST · PLTR

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-14-2026bullish

Transcript signals

Bull points

  • ARR grew 21% year over year to $493 million. We delivered adjusted EBITDA of $30.6 million, up 29% year over year.
  • The market narrative is clear. AI will create winners and losers.
  • We're now converting that promise to product, and within weeks and within the second quarter, we will begin to convert those products to bookings and revenues.

Bear points

  • this segment was essentially flat in 2025 driven primarily by a combination of budget pressures and organizational change.
  • We always knew Q1 growth would be modest given our seasonality and a small population of expiring contracts.
  • Q1 is historically one of our most difficult quarters
Read full transcript analysis ›